뭔가 하고 싶은 말이 있는거야?
컨텐츠 내용을 수정할 수 있습니다
Myelosuppression - Platelet monitoring - Neutropenia precautions - Thrombocytopenia care - Leukopenia awareness - CBC monitoring
A patient is receiving doxorubicin 60 mg/m² IV. The nurse must monitor for extravasation as this drug is a potent vesicant that can cause severe tissue necrosis if it leaks into surrounding tissues.
| Concept | Vesicant | Irritant | Non-vesicant |
|---|---|---|---|
| Definition | Causes tissue necrosis | Causes inflammation | No tissue damage |
| Examples | Doxorubicin, Vincristine | Carboplatin, Paclitaxel | Cyclophosphamide |
| IV Access | Central line preferred | Large peripheral vein | Any patent IV |
| Extravasation Risk | High - severe damage | Moderate - local reaction | Low - minimal risk |
Check two patient identifiers
Handling precautions (PPE)
Extravasation monitoring
Medication verification (double-check)
Organ toxicity assessment
다음 이론을 계속 학습하려면 로그인하세요.
로그인하고 계속 학습필기노트, 하이라이터, 메모는 잘 쓰고 있어?
내보내줘운영진이 검토할게요!
마이페이지에서 차단한 회원을 관리할 수 있어요.